Letter to House Committees on Energy and Commerce, Education and Labor and Ways and Means Regarding Surprise Billing Legislation

3/4/2020

rates are avoided, since such a benchmark would be tantamount to a national fee schedule, thereby … commercially reasonable rates. It is also crucial that any solution not reduce patient access to in-network … to consolidate, and health care costs doubled.  California’s surprise billing law sets out-of-network rates …

/Advocacy/Federal-Advocacy/Federal-Advocacy-Letters/Letter-to-House-Committees-on-Energy-and-Commerce,-Education-and-Labor-and-Ways-and-Means-Regarding-Surprise-Billing-Legislation/

Delegate Reimbursement Form

2/28/2020

*The Society will reimburse up to two nights at the MMS negotiated group rate of $295/night plus tax … and the current self-parking rate of $37/day* I certify that I am a delegate and that the above expenses were … before or between sessions of the House of Delegates at the negotiated MMS group rate (specific to each …

/Annual-Meeting/Hotel-Information/Delegate-Reimbursement-Form/

Delegate Reimbursement Form

2/28/2020

*The Society will reimburse up to two nights at the MMS negotiated group rate of $295/night plus tax … and the current self-parking rate of $37/day* I certify that I am a delegate and that the above expenses were … before or between sessions of the House of Delegates at the negotiated MMS group rate (specific to each …

/workarea/DownloadAsset.aspx?id=4294988710

Committee on Violence Intervention and Prevention - February 3, 2020

2/3/2020

Attendees Wendy Macias-Konstantopoulos, MD, MPH, chair, presiding Elaine J. Alpert, MD, MPH Adaugo Amobi, MD, MPH Christopher E. Barsotti, MD Ylisabyth S. Bradshaw, DO, MS Barbara Herbert, MD Ms. Margaret Igne Staff Candace Savage Administrative Approval of Minutes The minutes of t

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Violence-Intervention-and-Prevention---February-3,-2020/

VitalSigns_JanFeb_2020_

1/31/2020

/Publications/Vital-Signs---Member-Publication/VitalSigns_JanFeb_2020_/

Massachusetts Doctors Harness the Power of EHR in Practice

1/31/2020

By Vicki Ritterband, Vital Signs Writier One day, in the not-too-distant future, your electronic health record (EHR) will present you with a succinct summary of patients scheduled for the day. Front and center will be their primary medical issues and the interventions they’ll likely need. Than

/Templates/Article.aspx?id=4294984582

Apps Can Help Increase Screening of Social Determinants of Health

1/31/2020

By Kate Connors, Interim Vital Signs Editor Although addressing social determinants of health (SDOH) has been proven to improve patient outcomes, the clinical reality is that physicians and the members of their care teams are short on time and resources. Facing this reality, Massachusetts facilities are a

/Templates/Article.aspx?id=4294984583

Testimony Relative to an Act to Improve Health Care by Investing in Value Before the Joint Committee on Health Care Financing

1/20/2020

cost care across the health care system. As we face an increasingly aging population with high rates … at contracted or in-network rates if the physician participates in the carrier’s network but does not contract … Commission (HPC) at a “payment level equal to a percentage of the Medicare reimbursement rate.”  The Medical …

/Advocacy/State-Advocacy/State-Testimony/Testimony-Relative-to-an-Act-to-Improve-Health-Care-by-Investing-in-Value-Before-the-Joint-Committee-on-Health-Care-Financing/

HDMDSpotlight

12/13/2019

that results in higher rates of acute and chronic disease, behavioral and mental illness and substance use …

/HDMDSpotlight/

Testimony in Opposition to An Act to Update The Prescription Monitoring Program Before The Committee on Public Health

12/10/2019

, DPH estimates a 1% decrease in the rate of opioid-related overdose deaths compared with 2017 …. This follows an estimated 3% decline in the rate of opioid-related overdose deaths from 2016 to 2017. The rate …

/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Opposition-to-An-Act-to-Update-The-Prescription-Monitoring-Program-Before-The-Committee-on-Public-Health/